The Impact of Graft CD3+ T-Cell Dose on the Outcome of T-Cell Replete Human Leukocyte Antigen-Mismatched Allogeneic Hematopoietic Peripheral Blood Stem Cells Transplantation.

Saved in:
Bibliographic Details
Title: The Impact of Graft CD3+ T-Cell Dose on the Outcome of T-Cell Replete Human Leukocyte Antigen-Mismatched Allogeneic Hematopoietic Peripheral Blood Stem Cells Transplantation.
Authors: Halahleh K; Hematology Oncology and Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Mustafa R; Department of Internal Medicine, Hematology Oncology Section, King Hussein Cancer Center, Amman, Jordan., Sarhan D; Cell Therapy and Applied Genomics (CTAG Lab) laboratory, King Hussein Cancer Center, Amman, Jordan., Al Rimawi D; Biostatistics Unit, Research Office, King Hussein Cancer Center, Amman, Jordan., Abdelkhaleq H; Biostatistics Unit, Research Office, King Hussein Cancer Center, Amman, Jordan., Muradi I; Department of Internal Medicine, University of Tripoli, Tripoli, Libya Jamahiriya., Sultan I; Department of Pediatrics, Hematology and Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Source: Journal of hematology [J Hematol] 2023 Feb; Vol. 12 (1), pp. 27-36. Date of Electronic Publication: 2023 Feb 25.
Publication Type: Journal Article
Journal Info: Publisher: Elmer Press, Inc Country of Publication: Canada NLM ID: 101635099 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1927-1220 (Electronic) Linking ISSN: 19271212 NLM ISO Abbreviation: J Hematol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1927-1220
DOI:10.14740/jh1071